Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ESTA Establishment Labs	$44.36 +2.2%	$36.22	$26.56 ▼ $52.41	$1.26B	0.8	474,372 shs	378,561 shs
INGN Inogen	$7.42 +4.5%	$6.65	$5.70 ▼ $13.33	$190.90M	1.66	244,466 shs	247,505 shs
IVC Invacare		$0.50	$0.33 ▼ $2.53	$20.01M	0.38	240,305 shs	33,301 shs
SIEN Sientra		$0.43	$0.16 ▼ $4.94	$2.08M	2.04	4.15 million shs	3.44 million shs
SMTI Sanara MedTech	$29.94 +3.9%	$30.19	$25.86 ▼ $39.08	$256.06M	1.3	28,091 shs	85,319 shs

Elon Musk's Next Move

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ESTA Establishment Labs	+2.21%	+18.29%	+30.59%	+31.01%	+3.77%
INGN Inogen	+4.51%	+4.21%	+16.67%	+5.25%	-3.26%
IVC Invacare	0.00%	0.00%	0.00%	0.00%	0.00%
SIEN Sientra	0.00%	0.00%	0.00%	0.00%	0.00%
SMTI Sanara MedTech	+3.92%	+6.66%	+2.92%	+1.84%	+8.09%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ESTA Establishment Labs	1.2754 of 5 stars	2.4	1.0	0.0	0.0	1.5	2.5	0.6
INGN Inogen	4.3047 of 5 stars	3.3	4.0	0.0	3.9	2.7	1.7	0.6
IVC Invacare	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SIEN Sientra	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SMTI Sanara MedTech	2.2256 of 5 stars	3.5	1.0	0.0	0.0	2.7	1.7	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ESTA Establishment Labs	2.80	Moderate Buy	$52.40	18.12% Upside
INGN Inogen	2.50	Moderate Buy	$11.00	48.25% Upside
IVC Invacare	0.00	N/A	N/A	N/A
SIEN Sientra	0.00	N/A	N/A	N/A
SMTI Sanara MedTech	3.00	Buy	$49.50	65.33% Upside

Current Analyst Ratings Breakdown

Latest INGN, ESTA, IVC, SMTI, and SIEN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/16/2025	INGN Inogen	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$14.00
6/15/2025	INGN Inogen	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$14.00
6/13/2025	ESTA Establishment Labs	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$48.00
5/22/2025	INGN Inogen	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Moderate Buy	$12.00
5/16/2025	ESTA Establishment Labs	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy ➝ Buy	$62.00
5/15/2025	SMTI Sanara MedTech	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$51.00 ➝ $53.00
5/14/2025	ESTA Establishment Labs	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy	$48.00
5/8/2025	INGN Inogen	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$10.00 ➝ $7.00
4/14/2025	ESTA Establishment Labs	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Hold
4/9/2025	INGN Inogen	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold

(Data available from 7/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ESTA Establishment Labs	$166.02M	7.73	N/A	N/A	$1.90 per share	23.35
INGN Inogen	$335.70M	0.59	N/A	N/A	$7.30 per share	1.02
IVC Invacare	$872.46M	0.00	N/A	0.77	$5.54 per share	0.00
SIEN Sientra	$90.55M	0.00	N/A	N/A	($0.04) per share	0.00
SMTI Sanara MedTech	$86.67M	3.07	N/A	N/A	$4.45 per share	6.73

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ESTA Establishment Labs	-$84.60M	-$3.10	N/A	N/A	N/A	-52.34%	-196.25%	-26.64%	8/5/2025 (Estimated)
INGN Inogen	-$35.89M	-$1.15	N/A	N/A	N/A	-8.08%	-14.76%	-9.01%	8/5/2025 (Estimated)
IVC Invacare	-$45.56M	-$2.18	N/A	N/A	N/A	-9.99%	-37.76%	-7.18%	N/A
SIEN Sientra	-$73.31M	-$5.57	N/A	N/A	N/A	-65.93%	N/A	-40.45%	N/A
SMTI Sanara MedTech	-$9.66M	-$1.34	N/A	N/A	N/A	-12.48%	-29.22%	-13.20%	8/11/2025 (Estimated)

Latest INGN, ESTA, IVC, SMTI, and SIEN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/14/2025	Q1 2025	SMTI Sanara MedTech	-$0.31	-$0.41	-$0.10	-$0.41	$23.48 million	$23.43 million
5/7/2025	Q1 2025	ESTA Establishment Labs	-$0.83	-$0.70	+$0.13	-$0.70	$41.15 million	$41.38 million
5/7/2025	Q1 2025	INGN Inogen	-$0.52	-$0.25	+$0.27	-$0.25	$79.57 million	$82.28 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ESTA Establishment Labs	N/A	N/A	N/A	N/A	N/A
INGN Inogen	N/A	N/A	N/A	N/A	N/A
IVC Invacare	N/A	N/A	N/A	N/A	N/A
SIEN Sientra	N/A	N/A	N/A	N/A	N/A
SMTI Sanara MedTech	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ESTA Establishment Labs	5.72	3.36	2.05
INGN Inogen	N/A	3.07	2.67
IVC Invacare	4.82	1.32	0.78
SIEN Sientra	N/A	0.57	0.31
SMTI Sanara MedTech	1.18	2.77	2.54

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ESTA Establishment Labs	72.91%
INGN Inogen	89.94%
IVC Invacare	59.87%
SIEN Sientra	15.38%
SMTI Sanara MedTech	8.10%

Insider Ownership

Company	Insider Ownership
ESTA Establishment Labs	11.09%
INGN Inogen	1.46%
IVC Invacare	6.90%
SIEN Sientra	1.53%
SMTI Sanara MedTech	42.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ESTA Establishment Labs	1,018	28.92 million	25.71 million	Optionable
INGN Inogen	1,030	26.89 million	26.49 million	Optionable
IVC Invacare	3,000	37.76 million	35.15 million	Optionable
SIEN Sientra	304	11.96 million	11.78 million	Optionable
SMTI Sanara MedTech	60	8.89 million	5.10 million	Not Optionable

INGN, ESTA, IVC, SMTI, and SIEN Headlines

Recent News About These Companies

Cantor Fitzgerald Estimates Sanara MedTech FY2026 Earnings

June 11, 2025 | marketbeat.com

Sanara MedTech: Pursuing Rapid Expansion While Debt Levels Climb

June 9, 2025 | seekingalpha.com

Sanara MedTech Inc. (NASDAQ:SMTI) Short Interest Down 13.7% in May

June 5, 2025 | marketbeat.com

Sanara MedTech Shares Down, Investors Sought For Pilot Program

May 15, 2025 | marketwatch.com

Earnings call transcript: Sanara Medtech Q1 2025 earnings miss forecasts

May 15, 2025 | investing.com

Earnings call transcript: Sanara Medtech Q1 2025 earnings miss forecasts

May 15, 2025 | investing.com

Sanara MedTech Inc (SMTI) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Rising ...

May 15, 2025 | finance.yahoo.com

Sanara MedTech Inc (SMTI) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Rising ...

May 15, 2025 | finance.yahoo.com

Sanara MedTech Inc. (NASDAQ:SMTI) Q1 2025 Earnings Call Transcript

May 15, 2025 | msn.com

Sanara MedTech Inc. (NASDAQ:SMTI) Q1 2025 Earnings Call Transcript

May 15, 2025 | msn.com

Sanara MedTech Inc. (SMTI) Q1 2025 Earnings Call Transcript

May 14, 2025 | seekingalpha.com

Sanara MedTech Inc. (SMTI) Reports Q1 Loss, Tops Revenue Estimates

May 14, 2025 | zacks.com

Sanara MedTech Inc. Reports First Quarter 2025 Financial Results (Unaudited)

May 14, 2025 | gurufocus.com

Sanara MedTech Inc. Reports First Quarter 2025 Financial Results (Unaudited) | SMTI Stock News

May 14, 2025 | gurufocus.com

Sanara MedTech Inc. Reports First Quarter 2025 Financial Results (Unaudited)

May 14, 2025 | investing.com

Sanara MedTech Inc. Reports First Quarter 2025 Financial Results (Unaudited)

May 14, 2025 | globenewswire.com

With 31% ownership, Sanara MedTech Inc. (NASDAQ:SMTI) insiders have a lot riding on the company's future

May 6, 2025 | uk.finance.yahoo.com

Sanara MedTech Inc. to Report Q1 2025 Financial Results on May 14, 2025

April 23, 2025 | quiverquant.comQ

Sanara MedTech to Report First Quarter 2025 Financial Results on May 14, 2025

April 23, 2025 | globenewswire.com

Sanara MedTech to Present at Investor Showcase

April 22, 2025 | tipranks.com

Sanara MedTech to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

April 10, 2025 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Why BigBear.ai Could Rally 100% and Catch Palantir Soon
By Gabriel Osorio-Mazilli | June 30, 2025
View Why BigBear.ai Could Rally 100% and Catch Palantir Soon
IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
By Dan Schmidt | June 20, 2025
View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
Chime’s Smart IPO: Half the Valuation, Double the Strength
By Jeffrey Neal Johnson | June 18, 2025
View Chime’s Smart IPO: Half the Valuation, Double the Strength
Buybacks Galore: Repurchases From the Oval Office to Olive Garden
By Leo Miller | June 30, 2025
View Buybacks Galore: Repurchases From the Oval Office to Olive Garden
Darden Stock Set to Sizzle After Blowout Q4 and $1B Buyback
By Thomas Hughes | June 23, 2025
View Darden Stock Set to Sizzle After Blowout Q4 and $1B Buyback

INGN, ESTA, IVC, SMTI, and SIEN Company Descriptions

Establishment Labs NASDAQ:ESTA

$44.36 +0.96 (+2.21%)

Closing price 07/2/2025 04:00 PM Eastern

Extended Trading

$44.38 +0.02 (+0.03%)

As of 07/2/2025 04:04 PM Eastern

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

Inogen NASDAQ:INGN

$7.42 +0.32 (+4.51%)

Closing price 07/2/2025 04:00 PM Eastern

Extended Trading

$7.28 -0.14 (-1.94%)

As of 07/2/2025 04:28 PM Eastern

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Invacare NYSE:IVC

Invacare Corp. engages in the manufacture and distribution of medical equipment used in non-acute care settings. It focuses on medical device solutions for congenital, acquired, and degenerative ailments. The firm operates through the following segments: North America and Europe. The company was founded by Aaron Malachi Mixon III in 1979 and is headquartered in Elyria, OH.

Sientra NASDAQ:SIEN

Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides fat transfer systems; body contouring products; facial and nasal implants; saline filled sizers. It serves to hospitals, surgery centers, plastic surgeons, dermatologists, and other specialties. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Irvine, California. On February 12, 2024, Sientra, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Sanara MedTech NASDAQ:SMTI

$29.94 +1.13 (+3.92%)

Closing price 07/2/2025 04:00 PM Eastern

Extended Trading

$30.26 +0.32 (+1.08%)

As of 04:01 AM Eastern

Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. It also provides BIAKOS Antimicrobial Skin and Wound Cleanser, a patented product that contains synergistic ingredients that have been shown to impact mature biofilm microbes; BIAKOS Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing that helps against planktonic microbes, as well as immature and mature biofilms; and BIAKOS Antimicrobial Skin and Wound Irrigation Solution. In addition, it develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time